Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NVO
NVS
Add up to 3 more stocks
NVO
Novo Nordisk A/S
-0.21%
$37.32-0.08Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$165.72B
52W Range
$35.12 - $64.16
NVS
Novartis AG
-0.04%
$141.00-0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$268.00B
52W Range
$121.57 - $170.46
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 9.20 | 21.27 |
| Forward P/E | N/A | 16.02 |
| PEG Ratio | 0.47 | 1.38 |
| P/B Ratio | 4.91 | 6.45 |
| P/S Ratio | 3.25 | 4.82 |
| P/FCF Ratio | 22.25 | 16.94 |
| EV/EBITDA | 6.88 | 13.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 80.6% | 74.4% |
| Operating Margin | 43.1% | 30.5% |
| Net Margin | 35.3% | 22.9% |
| ROE | 53.5% | 30.7% |
| ROA | 19.9% | 10.5% |
| ROIC | 30.2% | 13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.87 | 0.86 |
| Quick Ratio | 0.66 | 0.67 |
| Debt/Equity | 0.63 | 1.18 |
| Interest Coverage | 30.34 | 14.38 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 4.8% | 3.4% |
| Payout Ratio | 44.3% | 71.5% |
| Yrs of Dividend Growth | 6 | 1 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.